PHRM Insider Trading Activity and SEC Form 4 Filings
PHRM insider trading summary
No open-market insider purchases or sales of Pharmion Corp (PHRM) have been reported on SEC Form 4 in the past 12 months.
Latest PHRM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 24, 2007 | Gillian C Ivers-Read | EVP, Development Operations | Sell | $348K (9,040 @ $38.50) |
| Aug 24, 2007 | Gillian C Ivers-Read | EVP, Development Operations | Sell | $77K (2,000 @ $38.55) |
| Aug 24, 2007 | Gillian C Ivers-Read | EVP, Development Operations | Sell | $308K (8,000 @ $38.53) |
| Aug 24, 2007 | Gillian C Ivers-Read | EVP, Development Operations | Sell | $31K (800 @ $38.54) |
| Aug 24, 2007 | Gillian C Ivers-Read | EVP, Development Operations | Sell | $154K (4,000 @ $38.52) |
| Aug 14, 2007 | Michael Cosgrave | EVP, Chief Commercial Officer | Sell | $428K (10,625 @ $40.32) |
| Aug 14, 2007 | Michael Cosgrave | EVP, Chief Commercial Officer | Sell | $107K (2,657 @ $40.32) |
| Aug 14, 2007 | Michael Cosgrave | EVP, Chief Commercial Officer | Sell | $971K (24,090 @ $40.32) |
| Aug 6, 2007 | Steven N Dupont | VP, General Counsel | Sell | $7K (160 @ $42.78) |
| Aug 6, 2007 | Steven N Dupont | VP, General Counsel | Sell | $136K (3,200 @ $42.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.